OR WAIT null SECS
© 2021 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
June 02, 2021
Outsourcing method development offers multiple benefits to companies, including access to experience and expertise, streamlined costs, and development time efficiencies.
May 16, 2021
The sensitivity of droplet digital PCR helps manufacturers detect Mycoplasma contamination in AAV-based gene therapy products.
May 02, 2021
Mass spectrometry and automation are growing in importance for protein characterization, but further improvements are still needed.
March 01, 2021
The acquisition strategically expands SPT Labtech’s offering in sample management for life sciences.
February 09, 2021
Model-based approaches and digital analytics are improving flexibility at both the equipment and the manufacturing-line level.
February 04, 2021
PathoQuest will apply its experience in viral safety testing and quality control of biologics for mitigating the risk of adventitious agent contamination in biopharmaceutical manufacturing.
February 02, 2021
Accelerated drug development timelines must accommodate all crucial elements of nonclinical safety studies.
Having a clear and detailed understanding of exactly what a biomolecule entails is essential for therapeutics development.
February 01, 2021
The £500,000 (US$686,294)-investment in mass spectrometry support will accelerate biologics development and approval.
January 05, 2021
Vendors are finding ways to address the increasingly complex analytical challenges in the biopharmaceutical industry to further biotherapeutic development.